|
| Press Releases |
|
 |
|
| Friday, August 29, 2025 |
|
|
Yunkang Group's 2025 Interim Net Loss Narrows, Demonstrating Strong Operational Resilience |
| Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"). more info >> |
|
| Monday, March 31, 2025 |
|
|
Yunkang's Revenue Proportion from Joint Construction Business for Medical Institution Alliances and Special Testing Items Continue to Grow in 2024 |
| Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2024 (the "Reporting Period"). During the year, the Group adhered to its overall business philosophy of "in-depth services and lean operations", promoted development with innovation, deepened integrated collaboration among "government, industry, academy, research, medicine, application", accelerated digital application of "AI + medical care", continuously strengthened refined management, and reduced cost and improved efficiency, demonstrating strong operational resilience. more info >> |
|
| Wednesday, August 28, 2024 |
|
|
Yunkang Group's 2024 Interim Revenue Reaches Approximately RMB380 Million |
| Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2024 (the "Reporting Period"). In the first half of 2024, the Group continued to deeply implement its overall business philosophy of 'in-depth services and lean operations'. more info >> |
|
| Friday, July 5, 2024 |
|
|
Hong Kong Investor Relations Association Announces Winners of the 10th IR Awards 2024 |
| The Hong Kong Investor Relations Association ("HKIRA") today announced the winners of the 10th Investor Relations Awards 2024 (the "IR Awards" or the "Awards"). more info >> |
|
| Friday, March 31, 2023 |
|
|
Yunkang Group Announces First Annual Results Since Listing |
| Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing. more info >> |
|
| Friday, August 12, 2022 |
|
|
Yunkang Group Announces First Interim Results Since Listing, Net Profit Rises 50% to RMB234 Million |
| Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first interim results for the six months ended 30 June 2022 (the "Reporting Period") since its listing. more info >> |
|
| Wednesday, May 18, 2022 |
|
|
Yunkang Group Limited Successfully Listed on the Main Board of HKEX |
| A medical operation services provider in China - Yunkang Group Limited ("Yunkang Group" or the "Company", stock code: 2325.HK, together with its subsidiaries, collectively as the "Group"), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") today, under the stock code of 2325 and in board lot of 500 shares each. more info >> |
|
| Thursday, May 5, 2022 |
|
|
Yunkang Group Limited Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange |
| A medical operation services provider in China - Yunkang Group Limited ("Yunkang Group" or the "Company", stock code: 2325.HK, together with its subsidiaries, collectively as the "Group"), today announced the proposed listing of its Shares on the Main Board of Hong Kong Exchanges and Clearing Limited ("Hong Kong Stock Exchange"). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
|
|
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT/SGT
|
|
|
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing
Dec 11, 2025 18:09 HKT/SGT
|
|
|
Nasdaq Verafin Joins Global Anti-Scam Alliance
Dec 11, 2025 14:21 HKT/SGT
|
|
|
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards
Dec 11, 2025 12:54 HKT/SGT
|
|
|
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
Dec 11, 2025 08:20 HKT/SGT
|
|
|
Indonesian Government's Swift Response in Recovering Flood-hit Sumatra
Dec 10, 2025 23:30 HKT/SGT
|
|
|
TIS Helps Treasury Teams Navigate the Ongoing ISO 20022 Transition After the 2025 Banking Deadline
Dec 10, 2025 21:00 HKT/SGT
|
|
|
'M' Mark Event - HKGX 2025 IBF World Championships 
Dec 10, 2025 15:58 HKT/SGT
|
|
|
HKiNEDA Annual Conference Successfully Concludes
Dec 10, 2025 15:11 HKT/SGT
|
|
|
Redefining Global Legal Services with Digital Intelligence China Entercom Empowers Yingke Law Firm to Win 2025 IDC China Future Enterprise Awards
Dec 10, 2025 14:37 HKT/SGT
|
|
|
Trio AI Partners with AbbyPay, a Member of PCG, to Pioneer the Future of AI-Powered Payments
Dec 10, 2025 12:12 HKT/SGT
|
|
|
Majority of Australian Parents (65%) and U.S. Parents 58% Support Social Media Ban for Under 16s, but Kids Say It Risks Cutting Them Off from Key Connections
Dec 9, 2025 22:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
